NCT06765473View on ClinicalTrials.gov

Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions

Postpartum Hemorrhage

Interventions

DRUG

Misoprostol

preoperative vaginal and postoperative sublingual administration of misoprostol (800 μg) to reducing the amount of blood loss during and 24 hours after CS to determine the optimum time for drug administration.

All Listed Sponsors

lead

Assiut University

OTHER